Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 316 Results
Palatin Technologies, Inc. Announces Completion of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease
August 5, 2020
Palatin Technologies Announces Mutual Termination of License Agreement with AMAG Pharmaceuticals for Vyleesi®
July 27, 2020
Palatin Technologies to Develop PL8177 as a Potential Treatment for COVID-19 and Associated Lung Complications
June 23, 2020
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights
May 12, 2020
Palatin Technologies Provides Assessment of Impact of COVID-19 Pandemic on Business Operations
April 30, 2020
Page 13 of 32